![Lisa Bollinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Bollinger
Chief Tech/Sci/R&D Officer at
POLARYX THERAPEUTICS, INC.
Net worth: 1 171 $ as of 31/05/2026
Profile
Lisa L.
Bollinger is an Independent Director at Apogee Therapeutics, Inc. since 2024 and Chief Medical Officer at Polaryx Therapeutics, Inc. starting in 2025.
Former roles include Associate Director-New Drug at the Center for Drug Evaluation & Research, Vice President-Global Regulatory Affairs, R&D at Amgen, Inc. from 2018 to 2021, and VP-Regulatory Affairs & Global Regulatory Affairs at Merck & Co., Inc. from 2021 to 2024.
Education includes a doctorate from Uniformed Services University of the Health Sciences and an undergraduate degree from the University of California.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/02/2026 | 358 ( 0% ) | 1 171 $ | 31/05/2026 | |
| 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Lisa Bollinger active positions
| Companies | Position | Start |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Director/Board Member | 28/05/2024 |
| POLARYX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2025 |
Former positions of Lisa Bollinger
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | General Counsel | 01/05/2024 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/03/2021 |
Center for Drug Evaluation & Research
 Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Corporate Officer/Principal | - |
Training of Lisa Bollinger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Uniformed Services University of the Health Sciences
 Uniformed Services University of the Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center for Drug Evaluation & Research
Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaryx Therapeutics, Inc.
 Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
- Stock Market
- Insiders
- Lisa Bollinger
